Andrea Zanichelli Selected Research

Body Weight (Weight, Body)

1/2018

Effectiveness of icatibant for treatment of hereditary angioedema attacks is not affected by body weight: findings from the Icatibant Outcome Survey, a cohort observational study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrea Zanichelli Research Topics

Disease

39	Hereditary Angioedemas 11/2023 - 04/2002
25	Angioedema 04/2023 - 09/2002
11	Acquired angioedema 04/2023 - 07/2010
4	Rare Diseases (Rare Disease) 12/2019 - 09/2013
3	Edema (Dropsy) 01/2018 - 06/2008
2	Infections 01/2024 - 10/2006
2	Hereditary Angioedema Types I and II 01/2019 - 11/2018
1	Heart Diseases (Heart Disease) 01/2024
1	Myocardial Infarction 01/2024
1	Substance Withdrawal Syndrome (Withdrawal Symptoms) 01/2022
1	Urticaria (Hives) 01/2020
1	Pruritus (Itching) 01/2020
1	Anaphylaxis (Anaphylactic Shock) 01/2020
1	Emphysema 01/2020
1	COVID-19 01/2020
1	Lung Diseases (Lung Disease) 01/2020
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2020
1	Hereditary Complement Deficiency Diseases 01/2020
1	Dizziness (Lightheadedness) 11/2018
1	Injection Site Reaction 11/2018
1	Overweight 01/2018
1	Body Weight (Weight, Body) 01/2018
1	Paraproteinemias (Monoclonal Gammopathy) 09/2013
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 09/2013
1	Abdominal Pain (Pain, Abdominal) 06/2008
1	Inborn Genetic Diseases (Disease, Hereditary) 06/2008
1	Nausea 06/2008
1	Insect Bites and Stings (Insect Bite) 10/2006
1	Autoimmune Diseases (Autoimmune Disease) 10/2006

Drug/Important Bio-Agent (IBA)

14	BradykininIBA 01/2022 - 09/2002
12	icatibantIBA 01/2019 - 08/2010
7	Complement C1 Inhibitor Protein (C1 Esterase Inhibitor)IBA 04/2021 - 06/2008
6	Complement System Proteins (Complement)IBA 01/2020 - 07/2010
4	Plasma KallikreinIBA 11/2023 - 01/2013
4	lanadelumabIBA 01/2023 - 11/2018
4	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 10/2016 - 10/2006
3	AndrogensIBA 01/2022 - 07/2010
3	Peptides (Polypeptides)IBA 09/2013 - 09/2002
2	sebetralstatIBA 11/2023 - 09/2023
2	Histamine (Histamine Dihydrochloride)FDA Link 01/2020 - 12/2016
2	Factor XII (Hageman Factor)IBA 01/2020 - 10/2016
2	Kininogens (Kininogen)IBA 01/2020 - 12/2017
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 09/2002
2	KininsIBA 12/2019 - 07/2010
2	AutoantibodiesIBA 09/2013 - 09/2002
2	Antifibrinolytic Agents (Antifibrinolytics)IBA 02/2013 - 07/2010
2	ecallantide FDA Link 01/2013 - 06/2008
1	COVID-19 VaccinesIBA 04/2023
1	Complement C1 (Complement 1)IBA 08/2021
1	PlasminogenIBA 01/2020
1	Angiopoietin-1IBA 01/2020
1	A-factor (Streptomyces)IBA 01/2020
1	Complement Inactivating AgentsIBA 01/2020
1	Monoclonal AntibodiesIBA 11/2018
1	berotralstatIBA 01/2018
1	Kallikreins (Kallikrein)IBA 01/2018
1	Secretory Phospholipases A2IBA 01/2018
1	acivicin (AT 125)IBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 12/2017
1	AntigensIBA 09/2017
1	Bradykinin B2 ReceptorIBA 09/2015
1	AntibodiesIBA 09/2013
1	Antihypertensive Agents (Antihypertensives)IBA 11/2011
1	Histamine Antagonists (Antihistamines)IBA 12/2010
1	Tranexamic Acid (AMCA)FDA Link 08/2010
1	Bradykinin Receptor AntagonistsIBA 08/2010
1	Capsules (Microcapsules)IBA 06/2008
1	Hormones (Hormone)IBA 09/2004
1	Anticardiolipin AntibodiesIBA 04/2002

Therapy/Procedure

16	Therapeutics 11/2023 - 02/2009
2	Self Administration (Administration, Self) 01/2020 - 10/2018
1	Appendectomy 01/2024
1	Dental Care 01/2020
1	Exercise Therapy (Therapy, Exercise) 01/2020
1	Oral Administration 01/2018